John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 63,583 shares at $148.00 ($9.4M) on 2021-02-25, disclosed to the SEC on 2021-02-26.
Seasonal sale ($9.4M) by Chief Executive Officer — this insider has traded ALNY in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.88 | 1,001 | $144K | 1.5% |
| 2 | $143.88 | 1,001 | $144K | 1.5% |
| 3 | $145.15 | 6,129 | $890K | 9.5% |
| 4 | $145.15 | 6,129 | $890K | 9.5% |
| 5 | $146.13 | 9,376 | $1.4M | 14.6% |
| 6 | $146.13 | 9,376 |
| $1.4M |
| 14.6% |
| 7 | $146.98 | 6,097 | $896K | 9.6% |
| 8 | $146.98 | 6,097 | $896K | 9.6% |
| 9 | $148.00 | 4,375 | $648K | 6.9% |
| 10 | $148.96 | 1,364 | $203K | 2.2% |
| 11 | $148.96 | 1,364 | $203K | 2.2% |
| 12 | $150.22 | 2,054 | $309K | 3.3% |
| 13 | $150.22 | 2,054 | $309K | 3.3% |
| 14 | $151.31 | 1,415 | $214K | 2.3% |
| 15 | $151.31 | 1,415 | $214K | 2.3% |
| 16 | $152.46 | 1,138 | $173K | 1.9% |
| 17 | $152.46 | 1,138 | $173K | 1.9% |
| 18 | $153.33 | 431 | $66K | 0.7% |
| 19 | $153.33 | 431 | $66K | 0.7% |
| 20 | $154.59 | 599 | $93K | 1.0% |
| 21 | $154.59 | 599 | $93K | 1.0% |
| Total | $147.26 avg | 63,583 | $9.4M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |
| ALNY | SELL | 2020-08-21 | $9.5M | — | Filing → |